NevaBio
Immunotherapy for Cancer Prevention
Health Tech & Life Sciences
Non Active, Apr 2021 ceased to operate
Company Overview
Snapshot
Founded in September 2017, NevaBio operated with 1–10 employees. The company ceased operations in April 2021.
Business overview
NevaBio is a Health Tech & Life Sciences company focused on the discovery and development of anticancer immunotherapy treatments. Operating within the Pharmaceuticals sector, the company's core technology is centered on developing novel immunotherapies aimed at cancer prevention, serving the broader healthcare and life sciences markets.
Log in to access full profile ›Company Intelligence Q&A
- What is NevaBio's primary focus?
- NevaBio is engaged in the discovery and development of anticancer immunotherapy treatments.
- When was NevaBio founded?
- NevaBio was founded in September 2017.
- What is the operational status of NevaBio?
- NevaBio ceased to operate in April 2021.
- In which sector does NevaBio primarily operate?
- NevaBio operates within the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Who are the Co-CEOs of NevaBio?
- Rinat Rotem-Yehudar and Moti Hacham serve as Co-CEOs of NevaBio.